I found this in the Journal of Drugs in Dermatoloy, May-June
2005 by Dr. Craig Burkhart Professor Medical College of Ohio.
The abstact states "Present dogma is based on herpesviruses (HSV-1 and HSV-2) residing only in the
dorsalParinaud syndrome root ganglion and laying dormant unless reactivated. Polymerase chain
reactionAllergic reactions
Allergic reactions to medication
Dermatitis, reaction to tinea
Drug allergies
Febrile/cold agglutinins
Insect bite reaction - close-up
Intradermal allergy test reactions
Positive reaction to allergen
Transfusion reaction has improved specificity and sensitivity so that tenets based on previous methodologies can be questioned. On point, negative serology, such as with anti-glycoprotein G protein antibodies for HSV-1 and HSV-2, does not rule out the presence of herpes. Indeed, exposure to the virus is probably universal, with individuals displaying varied immunological responses to the herpesviruses. There is a bimodal
temporalForehead lift
Temporal arteritis
Temporal lobe seizure distribution of
herpeticHerpetic stomatitis reactivation, explained by the existence of the virus in the epidermis as well as in the
dorsalParinaud syndrome root ganglion. Additionally, herpes may share a symbiotic relationship with
humansHcg in urine
Hiv infection
Human bites
Human papillomavirus vaccine, in which the body actually retains the virus within numerous body organs for its possible anti-cancer properties."
I was wondering if you knew of any other studies relating to this especially regarding its anti-cancer function or existance
bimodally in the skin and ganglion?
I cannot speak with authority about Dr. Burkhart's qualificaitons or credentials. I read the paper (not just the abstract). He expresses a hypothesis only, nothing proved. There may well be some sort of "synergistic relationship" between HSV and humans, but that statement applies to many viruses--perhaps all viruses that infect humans, depending on what he means by "synergistic". It is well known that some people with HSV remain seronegative with the best available serological tests, but it is rare.
In any case, there is nothing in this work that implies any difference in the current understanding of the clinical manifestations, diagnosis, or treatment of HSV infections.
Regards-- Hunter Handsfield, MD (MedHelp STD Forum)
other studies that support his conclusion regarding cancer.
However, it was not my intent to question any implications, right or wrong, that may be implied by the article.
My question is limited to whether anyone has seen other studies or artlicles regarding the subject.
Your help as always is much appreciated